Papillary thyroid cancer 4906140 226008538 2008-07-16T12:34:34Z Nephron 321400 +images of psammoma, papillary ca. {{Infobox_Disease | Name = {{PAGENAME}} | Image = Papillary_Carcinoma_of_the_Thyroid.jpg | Caption = Papillary thyroid carcinoma. | DiseasesDB = | ICD10 = {{ICD10|C|73||c|73}} | ICD9 = {{ICD9|193}} | ICDO = | OMIM = 603744 | MedlinePlus = | eMedicineSubj = med | eMedicineTopic = 2464 | MeshID = D013964 | }} [[Image:Psammoma.jpg|thumb|200px|right|A [[psammoma body]] in papillary carcinoma of the thyroid.]] '''Papillary thyroid cancer''' is the most common type of [[thyroid cancer]] in America, but not worldwide.{{Fact|date=April 2008}} It occurs more frequently in women and presents in the 30-40 year age group. It is also the predominant cancer type in children with thyroid cancer, and in patients with thyroid cancer who have had previous radiation to the head and neck (in this group, the cancer tends to be [[multifocal]] with early lymphatic spread, and portends a relatively poor prognosis). ==Markers== [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.<ref name="pmid18060877">{{cite journal |author=Lin JD |title=Thyroglobulin and human thyroid cancer |journal=Clin Chim Acta |volume= |issue= |pages= |year=2007 |pmid=18060877 |doi=10.1016/j.cca.2007.11.002}}</ref><ref name="pmid17673127">{{cite journal |author=Tuttle RM, Leboeuf R, Martorella AJ |title=Papillary thyroid cancer: monitoring and therapy |journal=Endocrinol. Metab. Clin. North Am. |volume=36 |issue=3 |pages=753–78, vii |year=2007 |pmid=17673127 |doi=10.1016/j.ecl.2007.04.004}}</ref> ==Pathology== *Characteristic [[Orphan Annie eye]] nuclear inclusions and [[psammoma]] bodies on light microscopy. The former is useful in identifying the follicular variant of papillary thyroid carcinomas.<ref name="pmid11442006">{{cite journal |author=Yang GC, Liebeskind D, Messina AV |title=Ultrasound-guided fine-needle aspiration of the thyroid assessed by Ultrafast Papanicolaou stain: data from 1135 biopsies with a two- to six-year follow-up |journal=Thyroid |volume=11 |issue=6 |pages=581–9 |year=2001 |pmid=11442006 |doi=10.1089/105072501750302895}}</ref> *Lymphatic spread is more common than [[hematogenous]] spread *Multifocality is common *The so-called [[Lateral Aberrant Thyroid]] is actually a lymph node metastasis from papillary thyroid carcinoma.<ref name="pmid17319317">{{cite journal |author=Escofet X, Khan AZ, Mazarani W, Woods WG |title=Lessons to be learned: a case study approach. Lateral aberrant thyroid tissue: is it always malignant? |journal=J R Soc Health |volume=127 |issue=1 |pages=45–6 |year=2007 |pmid=17319317 |doi=}}</ref> ==Prognosis== There are at minimum 13 known scoring systems for prognosis; among the more often used are: * AGES - Age, Grade, Extent of disease, Size * AMES - Age, Metastasis, Extent of disease, Size * MACIS - Metastasis, Age at presentation, Completeness of surgical resection, Invasion (extrathyroidal), Size<ref name="titleNew York Thyroid Center: Prognosis Staging for Thyroid Cancer">{{cite web |url=http://cpmcnet.columbia.edu/dept/thyroid/staging.html |title=New York Thyroid Center: Prognosis Staging for Thyroid Cancer |accessdate=2007-12-22 |format= |work=}}</ref> (this is a modification of the AGES system) * [[TNM]] - Tumor, node, metastasis. Remarkable about the TNM grading for (differentiated) thyroid carcinoma is that the scoring is different according to age. ==Treatment == Surgical treatment: *Minimal disease (diameter up to 1.0 centimeters) - [[hemithyroidectomy]] (or unilateral lobectomy) and [[isthmectomy]] may be sufficient. There is some discussion whether this is still preferable over total thyroidectomy for this group of patients. *Gross disease (diameter over 1.0 centimeters) - total [[thyroidectomy]], and central compartment lymph node removal is the therapy of choice. Additional lateral neck nodes can be removed at the same time if an ultrasound guided FNA and thyrobulin TG cancer washing was positive on the pre-operative neck node ultrasound evaluation. Arguments for total thyroidectomy are: *Reduced risk of recurrence, if central compartment nodes are removed at the original surgery. *Papillary carcinoma is a multifocal disease (hemithyroidectomy may leave disease in the other lobe) *Ease of monitoring with thyroglobulin (sensitivity for picking up recurrence is increased in presence of total thyroidectomy, and ablation of remnant normal thyroid by low dose radioiodine 131 after following a low iodine diet (LID). *Ease of detection of metastatic disease by thyroid and neck node ultrasound. Thyroid total body scans are less reliable at finding recurrence than TG and ultrasound. ==References== {{reflist|2}} {{Endocrine gland neoplasia}} [[Category:Otolaryngology]] [[Category:Thyroid disease]] [[Category:Oncology]] [[Category:Types of cancer]] [[es:Cáncer papilar tiroideo]]